Research on the Intervention of Virtual Reality Technology Based on TCM Syndrome Differentiation on Cardiovascular Severe Diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100004412

Enrollment

Unknown

Registered

2020-11-04

Start date

2020-11-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe cardiovascular disease

Interventions

2:??VR??

1:??VR??

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with severe cardiovascular diseases (mainly including acute heart failure, unstable angina pectoris, acute non ST segment elevation myocardial infarction and hypertension subacute) in our hospital from October 2020 to January 2021; 2. Patients aged 40-80 years; 3. Patients receiving VR treatment within 48 hours after admission.

Exclusion criteria

Exclusion criteria: 1. Patients with cardiogenic shock; 2. Patients with malignant arrhythmia; 3. Patients with acute ST segment elevation myocardial infarction.

Design outcomes

Primary

Measure	Time frame
Catecholamine;	—

Countries

China

Contacts

Public ContactShuwei Huang

The Second Affiliated Hospital of Zhejiang Chinese Medical University

hsw1104@163.com+86 13957121104

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026